KVYO chief legal officer reports Rule 10b5-1 stock sales

Q: What insider transaction did KVYO disclose in this Form 4?

The chief legal officer of Klaviyo, Inc. (KVYO) reported selling 10,374 shares of Series A common stock at a weighted average price of $27.83 per share and 4,020 shares at a weighted average price of $26.97 per share on 11/20/2025.

Q: Who is the reporting person in the KVYO Form 4 and what is their role?

The reporting person is an officer of Klaviyo, Inc. serving as the Chief Legal Officer , making them an insider required to report equity transactions.

Q: How many KVYO shares does the insider beneficially own after these transactions?

After the reported sales, the officer beneficially owns 376,472 shares, consisting of 122,874 shares of Series A common stock and 253,598 unvested restricted stock units.

Q: What do the unvested restricted stock units in the KVYO Form 4 represent?

The filing explains that the 253,598 unvested restricted stock units each represent a contingent right to receive one share of Klaviyo's Series A common stock upon vesting and settlement under the 2023 Stock Option and Incentive Plan.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Klaviyo, Inc. chief legal officer reports stock sales under a trading plan. The reporting officer sold 10,374 shares of Series A common stock on 11/20/2025 at a weighted average price of $27.83 per share and an additional 4,020 shares the same day at a weighted average price of $26.97 per share. These transactions were executed under a Rule 10b5-1 trading plan adopted by the officer. After these sales, the officer beneficially owns 376,472 shares, consisting of 122,874 shares of Series A common stock and 253,598 unvested restricted stock units that each represent the right to receive one share upon vesting and settlement.

Insider Trade Summary

Net Seller: 14,394 shares ($397,128)

Net Sell 2 txns

Insider Edmond Landon

Role Chief Legal Officer

Sold 14,394 shs ($397K)

Type	Security	Shares	Price	Value
Sale	Series A Common Stock	10,374	$27.83	$289K
Sale	Series A Common Stock	4,020	$26.97	$108K

Holdings After Transaction: Series A Common Stock — 380,492 shares (Direct)

Footnotes (1)

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.45 to $28.39 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.84 to $27.34 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Consists of (i) 122,874 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.

Form 4 Insider Transactions: What Each Field Means →

11/21/2025 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Edmond Landon

(Last)

(First)

(Middle)

C/O KLAVIYO, INC.

125 SUMMER STREET, 6TH FLOOR

(Street)

BOSTON

02110

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Klaviyo, Inc. [ KVYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Common Stock	11/20/2025		S⁽¹⁾		10,374	D	$27.83⁽²⁾	380,492	D
Series A Common Stock	11/20/2025		S⁽¹⁾		4,020	D	$26.97⁽³⁾	376,472⁽⁴⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.45 to $28.39 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.84 to $27.34 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Consists of (i) 122,874 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.

Remarks:

	/s/ Landon Edmond	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did KVYO disclose in this Form 4?

The chief legal officer of Klaviyo, Inc. (KVYO) reported selling 10,374 shares of Series A common stock at a weighted average price of $27.83 per share and 4,020 shares at a weighted average price of $26.97 per share on 11/20/2025.

Who is the reporting person in the KVYO Form 4 and what is their role?

The reporting person is an officer of Klaviyo, Inc. serving as the Chief Legal Officer, making them an insider required to report equity transactions.

Was the KVYO insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2025.

What prices were received for the KVYO shares sold in this filing?

The first sale had a weighted average price of $27.83 per share, with trades ranging from $27.45 to $28.39. The second sale had a weighted average price of $26.97, with trades ranging from $26.84 to $27.34.

How many KVYO shares does the insider beneficially own after these transactions?

After the reported sales, the officer beneficially owns 376,472 shares, consisting of 122,874 shares of Series A common stock and 253,598 unvested restricted stock units.

What do the unvested restricted stock units in the KVYO Form 4 represent?

The filing explains that the 253,598 unvested restricted stock units each represent a contingent right to receive one share of Klaviyo's Series A common stock upon vesting and settlement under the 2023 Stock Option and Incentive Plan.